Marimastat in Treating Patients With Stage III Non-small Cell Lung Cancer
Public ClinicalTrials.gov record NCT00002911. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A PHASE III, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF MARIMASTAT IN PATIENTS WITH MINIMAL DISEASE STAGE III NON-SMALL CELL LUNG CANCER
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
RATIONALE: Marimastat may stop the growth of non-small cell lung cancer by stopping blood flow to the tumor. PURPOSE: Randomized double-blinded phase III trial to determine the effectiveness of marimastat in treating patients who have residual stage III non-small cell lung cancer.
Study identification
- NCT ID
- NCT00002911
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- Not listed
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 1996 (Type not available)
- Primary completion
- Not listed
- Completion
- May 2004 (Actual)
- Last update posted
- Dec 18, 2013
1996 – 2004
United States locations
- U.S. sites
- 48
- U.S. states
- 22
- U.S. cities
- 41
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Comprehensive Cancer Institute of Huntsville | Huntsville | Alabama | 35801 | — |
| Hematology Associates, Ltd. | Phoenix | Arizona | 85013 | — |
| Marin Cancer Institute | Greenbrae | California | 94904 | — |
| Scripps Clinic | La Jolla | California | 92037 | — |
| Scripps Memorial Hospital Stevens Cancer Center | La Jolla | California | 92037 | — |
| USC/Norris Comprehensive Cancer Center | Los Angeles | California | 90033-0800 | — |
| St. Joseph Hospital - Orange | Orange | California | 92613-5600 | — |
| John Wayne Cancer Institute | Santa Monica | California | 90404 | — |
| Kaiser Permanente Medical Center - Vallejo | Vallejo | California | 94589 | — |
| Rocky Mountain Cancer Center | Denver | Colorado | 80218 | — |
| University of Colorado Cancer Center | Denver | Colorado | 80262 | — |
| University of Connecticut Health Center | Farmington | Connecticut | 06360-7106 | — |
| Vincent T. Lombardi Cancer Research Center, Georgetown University | Washington D.C. | District of Columbia | 20007 | — |
| Comprehensive Cancer Center at JFK Medical Center | Atlantis | Florida | 33462 | — |
| Radiation Therapy Associates - Fort Myers | Fort Myers | Florida | 33901 | — |
| Oncology-Hematology Group of South Florida | Miami | Florida | 33176 | — |
| Bay Area Oncology, MD'S, PA | Tampa | Florida | 33607-6381 | — |
| Rush-Presbyterian-St. Luke's Medical Center | Chicago | Illinois | 60612 | — |
| University of Chicago Cancer Research Center | Chicago | Illinois | 60637 | — |
| Community Hospitals of Indianapolis - Regional Cancer Center | Indianapolis | Indiana | 46219 | — |
| Memorial Hospital of South Bend | South Bend | Indiana | 46601 | — |
| Veterans Affairs Medical Center - Lexington | Lexington | Kentucky | 40511-1093 | — |
| Louisiana State University School of Medicine | New Orleans | Louisiana | 70112-2822 | — |
| Hubert H. Humphrey Cancer Center | Coon Rapids | Minnesota | 55433 | — |
| St. Louis University Health Sciences Center | St Louis | Missouri | 63110-0250 | — |
| Southwest Cancer Clinic | Henderson | Nevada | 89014 | — |
| Cancer Institute of New Jersey at Hamilton | Hamilton | New Jersey | 08690 | — |
| Beth Israel Medical Center | New York | New York | 10003 | — |
| Kaplan Cancer Center | New York | New York | 10016 | — |
| Strong Memorial Hospital of the University of Rochester | Rochester | New York | 14642 | — |
| Barrett Cancer Center, The University Hospital | Cincinnati | Ohio | 45219 | — |
| Ireland Cancer Center | Cleveland | Ohio | 44106-5065 | — |
| Natalie Warren Bryant Cancer Center | Tulsa | Oklahoma | 74136 | — |
| Abington Memorial Hospital | Abington | Pennsylvania | 19001 | — |
| Hematology-Oncology Mawr Medical North | Bryn Mawr | Pennsylvania | 19010 | — |
| Milton S. Hershey Medical Center | Hershey | Pennsylvania | 17033 | — |
| University of Pennsylvania Cancer Center | Philadelphia | Pennsylvania | 19104 | — |
| Care Group | Philadelphia | Pennsylvania | 19145 | — |
| Allegheny University Hospitals - Graduate MCP | Philadelphia | Pennsylvania | 19146 | — |
| University of Pittsburgh Cancer Institute | Pittsburgh | Pennsylvania | 15213 | — |
| Pittsburgh Pediatric Research, Inc. | Pittsburgh | Pennsylvania | 15216 | — |
| Roger Williams Medical Center/BUSM | Providence | Rhode Island | 02908-4735 | — |
| Jackson Clinic Professional Association | Jackson | Tennessee | 38301 | — |
| Baptist Regional Cancer Center - Knoxville | Knoxville | Tennessee | 37901 | — |
| Texas Oncology PA (TOPA) at Baylor-Sammons | Dallas | Texas | 75246 | — |
| University of Texas Medical Branch | Galveston | Texas | 77555-1329 | — |
| University of Texas - MD Anderson Cancer Center | Houston | Texas | 77030 | — |
| Joe Arrington Cancer Research and Treatment Center | Lubbock | Texas | 79410-1894 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00002911, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 18, 2013 · Synced Nov 9, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00002911 live on ClinicalTrials.gov.